NCT04557163View on ClinicalTrials.gov

Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 13, 2020

Primary Completion Date

November 14, 2020

Study Completion Date

November 14, 2020

Conditions

Healthy Subjects

Interventions

DRUG

TS-142

TS-142 will be given as 1 mg per capsule administered orally with water.

DRUG

Itraconazole

Itraconazole will given as 50 mg per capsule administered orally with water.

Trial Locations (1)

Unknown

Taisho Pharmaceutical Co., Ltd selected site, Tokyo

All Listed Sponsors

lead

Taisho Pharmaceutical Co., Ltd.

INDUSTRY

NCT04557163 - Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole) | Biotech Hunter | Biotech Hunter